Chemical Research in Chinese Universities ›› 2013, Vol. 29 ›› Issue (5): 1003-1005.doi: 10.1007/s40242-013-3127-2

• Articles • Previous Articles     Next Articles

Novel PLGA Microspheres for Sustained Delivery of Antisense Oligonucleotide

XIE Jing1,2, LI Xin3, JIANG Chao-jun1, LEE Robert Jian-guang1,2, ZHOU Yu-lin1, TENG Le-sheng1,2   

  1. 1. College of Life Science, Jilin University, Changchun 130012, P. R. China;
    2. College of Pharmacy, Ohio State University, Columbus 43210, USA;
    3. The Second Hospital of Jilin University, Changchun 130041, P. R. China
  • Received:2013-03-19 Revised:2013-04-24 Online:2013-10-01 Published:2013-09-17
  • Contact: TENG Le-sheng E-mail:tenglesheng@jlu.edu.cn
  • Supported by:

    Supported by the National Natural Science Foundation of China(Nos.30870251, 31070309).

Abstract:

Novel poly(lactide-co-glycolide acid)(PLGA) microspheres were developed for sustained delivery of antisense oligonucleotide(ASO). First, a new cationic agent, polyethylenimine(PEI) conjugated to linoleic acid(LA)(PEI-LA) was synthesized by reacting PEI(Mw=800) with linoleoyl chloride. Then, PEI-LA was combined with LOR-2501 to form electrostatic complexes at moderate nitrogen-to-phosphate(N/P) molar ratios which were then encapsulated into poly(lactide-co-glycolide) microspheres by a multiple emulsion-solvent evaporation technique. With an increase in ASO/PEI-LA concentration from 5% to 10%, encapsulation efficiency of ASO in the microspheres reduced from 72.14% to 57.62%, and the particle size of microspheres increased from 28.58 μm to 34.76 μm. In vitro studies show that the release profile of ASO from microspheres prepared at 7.5% ASO-PEI-LA lasted for 14 d. The novel microspheres have a potential use as a sustained release vehicle for ASO.

Key words: Drug delivery, PLGA microsphere, Polyethylenimine, Antisense oligonucleotide